Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells

Fortunata Iacopino, Pierluigi Navarra, Raffaella Urbano, Gigliola Sica, Grazia Graziani, Alessia Muzi

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

20 Citazioni (Scopus)

Abstract

Histone deacetylase (HDAC) inhibitors are currently undergoing clinical trials in cancer patients on the basis of their effect on proliferation, differentiation and apoptosis demonstrated in vitro. The goal of this study was to assess the effects of an HDAC inhibitor, valproic acid (VA), on proliferation, androgen-sensitivity, androgen receptor levels and E-cadherin (E-cad) expression in human prostate cancer cells. The effects of VA were evaluated in androgen-sensitive, LNCaP and -insensitive PC-3 human prostate cancer cell lines. Proliferation was assayed by cell counts and protein expression by Western blot analysis. Morphological changes were analysed under an inverted phase contrast microscope. High VA concentrations (1-25 mM) induced a very strong reduction in cell numbers ( approximately 90% with respect to control) of the two cell lines due to drug cytotoxicity. A low concentration (0.45 mM VA) slightly reduced (14%) LNCaP cell proliferation and abolished the response to androgen. In the PC-3 cells, the same concentration of VA had a more pronounced (40%) inhibitory effect and induced a response to dihydrotestosterone in terms of an enhancement in cell growth. These events were associated with morphological changes, an absence of cytotoxicity, an increase in androgen receptor levels, and, in PC-3 cells, an enhancement in E-cad expression which may be ascribed to VA differentiative action. Our findings, obtained with a VA dose (0.45 mM), which is consistent with plasma concentrations reached under oral administration of therapeutical doses in patients treated for different diseases, suggest that VA might have clinical value in prostate cancer therapy in androgen-sensitive and -insensitive tumors.
Lingua originaleEnglish
pagine (da-a)1293-1303
Numero di pagine11
RivistaInternational Journal of Oncology
Stato di pubblicazionePubblicato - 2008

Keywords

  • ANDROGEN RECEPTOR
  • DIFFERENTIATION
  • HORMONE-SENSITIVITY
  • PROSTATE CANCER CELLS
  • VALPROIC ACID

Fingerprint

Entra nei temi di ricerca di 'Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells'. Insieme formano una fingerprint unica.

Cita questo